Home
About
Services
Partners
Client Portfolio
News
Contact
HSBC HK shareholders mull legal action over dividend suspension
April 6, 2020
Uber connects out-of-work U.S. ride-hail drivers to delivery, production jobs
April 6, 2020
0
GSK to partner with Vir for potential COVID-19 treatments, invest $250 million
Published by
Muller&Green
at
April 6, 2020
Categories
RSS
Tags
British drugmaker GlaxoSmithKline will invest $250 million in Vir Biotechnology Inc and collaborate to develop potential treatments for COVID-19, the disease caused by the new coronavirus, the companies said on Monday.
Powered by
WPeMatico
Muller&Green
Related posts
December 17, 2024
Five Lessons From My Mentor
Read more
December 13, 2024
Where Does Corporate Climate Action Go Next?
Read more
December 12, 2024
CEO of the Year Lisa Su Talks Competition and Collaboration in the Semiconductor Industry
Read more